X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
1
Enter email and you're done. No subscription, no credit card.
2
Search, tap and you're done. Over 3,400 medicines.
3
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
Oxycodone is a strong opioid on step III of the WHO ladder and is used for severe acute and chronic pain. It falls under Germany's narcotic drugs prescribing rules and is usually taken as a prolonged-release tablet on a fixed 12-hour rhythm. Constipation occurs in almost everyone treated with it and persists throughout the treatment — which is why it should be treated alongside from the very start.
See more detail.gif)
Fixed dosing times, a reminder and your pain record in one place — free in the brite app.
| Property | Details |
|---|---|
| Active ingredient | Oxycodone (as oxycodone hydrochloride) |
| ATC code | N02AA05 |
| Drug class | Strong opioid painkiller (WHO step III) |
| Dosage forms | Prolonged-release tablets (12-hour action), immediate-release capsules and orodispersible tablets, oral solution, solution for injection; also as a combination with naloxone (Targin, for example) |
| Half-life | Around 3 to 5 hours; prolonged-release tablets release the drug gradually over about 12 hours |
| Maximum daily dose | No rigid upper limit — according to the SmPC the dose is titrated individually against the severity of the pain and set by the treating practice |
| Onset of effect | Immediate-release forms after about 20 to 30 minutes, prolonged-release tablets noticeably after around 1 hour |
| Prescription status | A controlled drug — only on a narcotics prescription (BtM-Rezept), which is valid for 8 days |
| Notable feature | Prolonged-release tablets must never be split, chewed or crushed; constipation affects almost everyone and is treated alongside from the start |
Oxycodone binds to opioid receptors — above all to the µ receptor — in the brain and spinal cord. There it damps down both the transmission and the appraisal of pain signals: the pain is felt less strongly and loses its threatening quality.¹ Unlike anti-inflammatory painkillers, then, oxycodone does not work at the site of the damage but on the way the nervous system processes it.
But those same receptors do not sit only in the pain pathways — and that is exactly where the typical side effects come from:
Whether and when a strong opioid makes sense depends on the cause of the pain: in cancer pain and severe acute pain the benefit is well established, while in chronic non-cancer pain oxycodone is, according to the guideline, an option for selected situations — not the first and not the only building block of treatment.
The figures below describe the approach set out in the SmPC and the guideline — not a recommendation on how to take it. Your dose is set by the treating practice and adjusted step by step.
Oxycodone comes in two fundamentally different forms, which have different jobs:
Your health record shows the practice exactly what it needs to get the dose right.
The side effects of oxycodone fall into two groups: those the body gets used to — and one where that never happens.
Opioid-induced constipation affects practically everyone who takes a strong opioid long term. It arises directly at the opioid receptors of the bowel wall and — this is the crucial difference from nausea and tiredness — it does not ease off with time.³ That is why the rule in pain medicine is: the laxative is prescribed alongside from the start, not only once nothing is moving at all.
Around the start of treatment, nausea is common. It arises in the vomiting centre of the brain — and there the body usually adapts within a week. For the interim the practice can prescribe something for nausea. Worth knowing: nausea at the start is no proof of an “intolerance” and rarely a reason to break off treatment.
The most dangerous side effect of oxycodone is the damping of the drive to breathe. On a stable, correctly titrated dose it is rare — what makes it dangerous is almost always combinations:
Extra caution also applies with sleep apnoea, severe COPD and other lung conditions — here the dose is kept particularly low and monitoring is close. On alcohol in detail: medications and alcohol.
| Combination | Consequence | What to do |
|---|---|---|
| Alcohol | Stronger sedation and respiratory depression, unpredictable drug levels | Go without during treatment |
| Benzodiazepines (e.g. lorazepam) and Z-drugs | A markedly raised risk of respiratory depression up to respiratory arrest | Only where a doctor has expressly prescribed it that way; avoid all self-medication |
| Other sedating agents (sedating antidepressants, antihistamines, pregabalin/gabapentinoids) | Tiredness and respiratory depression add up | Have your overall medication reviewed regularly |
| CYP3A4 inhibitors (e.g. clarithromycin, ketoconazole, and grapefruit juice too) | Oxycodone is broken down more slowly — effect and side effects increase | Always check new medicines against the opioid treatment |
| CYP3A4 inducers (e.g. rifampicin, carbamazepine, St John's wort) | Faster breakdown — breakthrough pain, and a risk of overdose when the inducer is stopped | Mention herbal preparations as well |
| Serotonergic medicines (certain antidepressants) | In rare cases serotonin syndrome (restlessness, fever, muscle twitching) | Know the warning signs, get them checked medically |
| MAO inhibitors | Severe, unpredictable reactions possible | Avoid the combination; keep the interval given in the SmPC |
The combinations with benzodiazepines and alcohol are by far the most dangerous — which is why they are set out at length in section 6. The unremarkable rest matters in practice too: a new antibiotic, a St John's wort preparation from the chemist or a glass of grapefruit juice in the evening can shift the oxycodone level measurably. Check combinations in the guide to drug interactions or directly in the interaction check in the brite app.
Hardly any subject carries so much fear — and is so often explained sloppily. Three terms that belong apart:
For everyday life that means: if you take your opioid as prescribed and notice withdrawal symptoms after months when you miss a dose, that does not make you an addict. Conversely, raising the dose on your own and taking it “against the stress” are warning signs that belong discussed openly at the practice — the earlier, the easier the solution.²
Tapering rather than stopping: after longer treatment, oxycodone is reduced step by step — typically in small steps over weeks, and after very long treatment over months. There is no blanket timetable; the pace depends on how long you have taken it, on the dose and on how you feel. Stopping abruptly produces unnecessary withdrawal symptoms and makes pain seem temporarily worse than it is — which then gets misread as “proof” that the opioid is needed. The basics are in the guide stopping medications.
For pain treatment the WHO established a stepped ladder that still provides the orientation today:
| WHO step | Drug group | Examples |
|---|---|---|
| Step I | Non-opioid painkillers | Ibuprofen, paracetamol, metamizole |
| Step II | Weak opioids, often combined with step I | Tramadol, tilidine (with naloxone) |
| Step III | Strong opioids | Oxycodone, morphine, hydromorphone, fentanyl |
Oxycodone therefore sits on the top step: it is markedly more potent than tramadol or tilidine and, unlike them, falls under Germany's narcotic drugs prescribing regulation (Betäubungsmittel-Verschreibungsverordnung). Moving to step III is not automatic but a deliberate decision — the ladder is handled more flexibly today than it used to be, and not every pain has to work through the steps in order. For an overview of the whole painkiller landscape, see the guide painkillers compared.
The combination of oxycodone and naloxone (known as Targin) targets the constipation problem: naloxone blocks the opioid receptors in the bowel but is almost completely broken down on its first pass through the liver — so it acts locally in the bowel without cancelling out the pain relief in the brain. In many people treated with it the constipation is milder as a result. The combination is no free pass, though: some still need a laxative, and where liver function is severely impaired the principle does not work reliably. Whether the combination or oxycodone plus a separate laxative makes more sense is decided by the treating practice.
In older age the starting dose is lower and increases are slower: breakdown slows down, drowsiness and unsteadiness raise the risk of falls, and the opioid-induced constipation meets a bowel that is already more sluggish. Together with other sedating medicines a risky total builds up quickly — a systematic look at the overall medication is worth it, see medications in old age.
Kidneys and liver: where kidney function is impaired, oxycodone and its breakdown products can accumulate — the dose is reduced or the interval between doses lengthened. Where liver function is disturbed, the amount of drug available rises markedly; severe liver failure is a contraindication for the naloxone combination. Background in the guide medications for kidney and liver disease.
Pregnancy and breastfeeding: oxycodone is not a first choice in pregnancy. After longer use up to the birth, the newborn can develop withdrawal symptoms and difficulty adapting its breathing; Embryotox advises using opioids in pregnancy only where there is a clear indication and for as short a time as possible.⁴ If you become pregnant while on opioid treatment, do not stop anything abruptly — sudden withdrawal is a strain on the baby too — but speak to your practice straight away. For orientation: medications during pregnancy.
As a controlled drug, oxycodone follows rules of its own — at home as well:
The most important step is a change of perspective: opioid-induced constipation is not an annoying footnote but a lasting side effect that needs treating. A regularly taken osmotic laxative such as macrogol is the basis — not as an emergency measure but as a fixed part of the medication plan. If that is not enough, there are further steps, up to agents that specifically block the opioid receptors in the bowel. The key thing: raise the subject openly instead of feeling embarrassed — it affects practically everyone on this treatment.
No — but the distinction matters. Physical dependence, with withdrawal symptoms on stopping, develops in almost everyone after weeks of taking it; that is expected and is solved by tapering slowly. Addiction with loss of control is something else, and it affects a proportion of those treated, particularly where there are risk factors. The best protection is clear treatment goals, fixed dosing times, a single prescribing practice and regular review of whether the opioid is still the right medicine.
The phenomenon is well known: in some people the effect wears off after 8 to 10 hours (“end-of-dose failure”). The answer to that is not an extra tablet on your own initiative but feedback to the practice — recorded with times and pain severity. Possible responses then include adjusting the individual doses or the dosing times. This is exactly where a complete pain diary pays off.
Yes, with preparation: within the Schengen area you need a certificate for carrying the medicine, filled in by a doctor and certified by the responsible authority; other countries have their own rules, which you should clear up in good time — several weeks beforehand. The medicine belongs in your hand luggage, in its original packaging, in sufficient quantity plus a reserve. Details and checklists in the guide medications when travelling.
The interaction check warns you about risky combinations before you take them.
A reminder every 12 hours, your pain record and an interaction check in one place. Free.
Create medication plan